Evidence map›Paper›PMID 37007016›Full record

ArticleFrontiers in pharmacology2023

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice.

Jingyi Wu, Shu Jia, Benhong Xu, Xiaokun Yao, Jingping Shao, Jianzuo Yao, Danwei Cen, Xiaomin Yao

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Frontiers in pharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jingyi WuFaculty of Pharmacy, Zhejiang Pharmaceutical University, Ningbo, China.
Shu JiaFaculty of Pharmacy, Zhejiang Pharmaceutical University, Ningbo, China.
Benhong XuShenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shengzhen, Guangdong, China.
Xiaokun YaoFaculty of Pharmacy, Zhejiang Pharmaceutical University, Ningbo, China.
Jingping ShaoFaculty of Pharmacy, Zhejiang Pharmaceutical University, Ningbo, China.
Jianzuo YaoDepartment of Hepatobiliary and Pancreatic Surgery, Li Huili Hospital Affiliated to Ningbo University, Ningbo, China.
Danwei CenFaculty of Pharmacy, Zhejiang Pharmaceutical University, Ningbo, China.
Xiaomin YaoFaculty of Pharmacy, Zhejiang Pharmaceutical University, Ningbo, China.
Zhejiang Pharmaceutical College · CNNingbo University · CNShenzhen Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bicyclolmultiple pathwaysNAFLDNASHproteomics

Identifiers

PMID37007016
PMCPMC10063911
OpenAlexW4327735407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.